141 related articles for article (PubMed ID: 32785769)
1. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.
Sun C; Wang S; Chatterjee A; Medved M; Eggener S; Karczmar GS; Oto A
Eur Radiol; 2021 Jan; 31(1):325-332. PubMed ID: 32785769
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.
Wang S; Fan X; Yousuf A; Eggener SE; Karczmar G; Oto A
J Magn Reson Imaging; 2019 May; 49(5):1374-1380. PubMed ID: 30291653
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.
Knull E; Oto A; Eggener S; Tessier D; Guneyli S; Chatterjee A; Fenster A
Med Phys; 2019 Feb; 46(2):800-810. PubMed ID: 30447155
[TBL] [Abstract][Full Text] [Related]
4. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
6. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
[TBL] [Abstract][Full Text] [Related]
7. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
8. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
9. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
10. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
[TBL] [Abstract][Full Text] [Related]
11. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
Westin C; Chatterjee A; Ku E; Yousuf A; Wang S; Thomas S; Fan X; Eggener S; Karczmar G; Oto A
AJR Am J Roentgenol; 2018 Sep; 211(3):595-604. PubMed ID: 29995499
[TBL] [Abstract][Full Text] [Related]
12. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
13. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
14. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
[TBL] [Abstract][Full Text] [Related]
15. Toward mechatronic MRI-guided focal laser ablation of the prostate: Robust registration for improved needle delivery.
Knull E; Park CKS; Bax J; Tessier D; Fenster A
Med Phys; 2023 Mar; 50(3):1259-1273. PubMed ID: 36583505
[TBL] [Abstract][Full Text] [Related]
16. Identifying Quantitative
Viswanath S; Toth R; Rusu M; Sperling D; Lepor H; Futterer J; Madabhushi A
Neurocomputing (Amst); 2014 Nov; 144():13-23. PubMed ID: 25346574
[TBL] [Abstract][Full Text] [Related]
17. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones.
Rempp H; Unterberg J; Hoffmann R; Pereira PL; Schick F; Claussen CD; Clasen S
Invest Radiol; 2013 Jun; 48(6):429-36. PubMed ID: 23511192
[TBL] [Abstract][Full Text] [Related]
18. [MRI monitoring before, during and after interstitial laser-induced hyperthermia of benign prostatic hyperplasia. Initial clinical experiences].
Müller-Lisse GU; Heuck A; Stehling MK; Frimberger M; Thoma M; Schneede P; Muschter R; Hofstetter A; Reiser M
Radiologe; 1996 Sep; 36(9):722-31. PubMed ID: 8999449
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
20. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]